Verified Nov 2026
Electronics & Software
·

Slough, England
·
Since 1979
Otsuka Pharmaceutical Europe Ltd. is the European regional headquarters for Japan-based Otsuka Pharmaceutical Co., Ltd., operating from Slough, England since its UK establishment in 1998. The private company employs 500–1,000 staff and generates estimated revenues of $250–500M annually. It develops and distributes pharmaceuticals, nutraceutical products, and clinical nutrition solutions across Europe, focusing on cardiovascular, gastrointestinal, and central nervous system disorders. In January 2026, the company obtained European Union marketing authorization for donidalorsen to treat hereditary angioedema.
Otsuka Pharmaceutical Companies Europe at a glance
Revenue
$250-500M
Est. band
Employees
500-1,000
Founded
1979
Headquarters
Slough, England
Certifications
ISO 13485 · ISO 14001 · ISO 9001
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
Industrial Equipment
STABILITY SIGNALS
Established & active
47 years in operation (founded 1979).
Holds ISO 13485, ISO 14001, ISO 9001 certification(s) per public sources.
Overview
Otsuka Pharmaceutical Europe Ltd. is the European regional headquarters for Japan-based Otsuka Pharmaceutical Co., Ltd., operating from Slough, England since its UK establishment in 1998. The private company employs 500–1,000 staff and generates estimated revenues of $250–500M annually. It develops and distributes pharmaceuticals, nutraceutical products, and clinical nutrition solutions across Europe, focusing on cardiovascular, gastrointestinal, and central nervous system disorders. In January 2026, the company obtained European Union marketing authorization for donidalorsen to treat hereditary angioedema.
At a glance
Attribute | Detail |
|---|---|
Founded | 1979 |
Headquarters | Slough, England |
Employees | 500-1,000 |
Revenue | $250-500M (estimated) |
Primary capability | Electronics & Software |
Certifications | ISO 13485 · ISO 14001 · ISO 9001 |
What Otsuka Pharmaceutical Companies Europe makes
Otsuka maintains ISO 13485, ISO 14001, and ISO 9001 certifications and delivers specialty pharmaceuticals for neuroscience, nephrology, and haemato-oncology, alongside digital health solutions.
Certifications
Otsuka Pharmaceutical Companies Europe is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — otsuka.com
ISO 14001 — otsuka.co.jp
ISO 9001 — otsuka.com
Latest developments
2026-09-10 — Amgros Awards DKK 97.4M Pharmaceutical Framework to Otsuka Pharma Scandinavia AB | DenmarkTenders Blog (denmarktenders.com)
2026-01-21 — DawnzeraTM (donidalorsen) granted European Union marketing authorisation for the prevention of hereditary angioedema|January 21, 2026|News Releases | Otsuka Pharmaceutical Co., Ltd. (otsuka.co.jp)
2025-12-15 — GENESIS Pharma announces a new partnership with Otsuka Pharmaceutical Europe Ltd. for the commercialization of donidalorsen for hereditary angioedema in Central and Eastern Europe (genesispharma.com)
2025-11-05 — Exp. CONTR 2025 0000542669 · 1º cbam otsuka pharmaceutical, sa., am 777/2022 suministro de… | El Vínculo (el-vinculo.com)
2025-10-03 — Exp. CONTR 2025 0000542549 · cca +6.6pwpjk5 cbam 777/2022 otsuka pharmaceutical/01 acuerdo… | El Vínculo (el-vinculo.com)
2025-03-13 — Rxulti® (brexpiprazole) approved in the European Union for the treatment of schizophrenia in adolescents aged 13 years and older|March 13, 2025|News Releases | Otsuka Pharmaceutical Co., Ltd. (otsuka.co.jp)
Facilities
Otsuka Pharmaceutical Companies Europe is headquartered in Slough, England. Public sources also reference these locations:
France, Germany — otsuka-europe.com
England — otsuka-europe.com
Company details
The company operates across France, Germany, and England, serving unmet medical needs in specialty pharmaceuticals and clinical nutrition within European healthcare markets. Otsuka Pharmaceutical Companies Europe was founded in 1979, has an estimated 500-1,000 employees, and is headquartered in Slough, England. On the LightSource stability read it is rated "Established & active": 47 years in operation (founded 1979). Holds ISO 13485, ISO 14001, ISO 9001 certification(s) per public sources.
Frequently asked questions
What does Otsuka Pharmaceutical Companies Europe make?
Otsuka Pharmaceutical Europe Ltd. is the European regional headquarters for Japan-based Otsuka Pharmaceutical Co., Ltd., operating from Slough, England since its UK establishment in 1998. The private company employs 500–1,000 staff and generates estimated revenues of $250–500M annually. It develops and distributes pharmaceuticals, nutraceutical products, and clinical nutrition solutions across Europe, focusing on cardiovascular, gastrointestinal, and central nervous system disorders. In January 2026, the company obtained European Union marketing authorization for donidalorsen to treat hereditary angioedema.
Where is Otsuka Pharmaceutical Companies Europe headquartered?
Otsuka Pharmaceutical Companies Europe is headquartered in Slough, England.
When was Otsuka Pharmaceutical Companies Europe founded?
Otsuka Pharmaceutical Companies Europe was founded in 1979.
How big is Otsuka Pharmaceutical Companies Europe?
Otsuka Pharmaceutical Companies Europe has an estimated 500-1,000 employees, with revenue in the $250-500M range (estimated).
What certifications does Otsuka Pharmaceutical Companies Europe hold?
Otsuka Pharmaceutical Companies Europe lists ISO 13485 · ISO 14001 · ISO 9001 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Phone
'+44 20 3747 5000
Certification
ISO 13485 · ISO 14001 · ISO 9001
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
